Authors: Dowell, JA Korth-Bradley, J Milisci, M Tantillo, K Amorusi, P Tse, S

Citation: Ja. Dowell et al., Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment, J CLIN PHAR, 41(9), 2001, pp. 979-986

Authors: Dowell, JA Korth-Bradley, J Liu, HJ King, SP Berger, MS

Citation: Ja. Dowell et al., Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in firstrelapse, J CLIN PHAR, 41(11), 2001, pp. 1206-1214

Authors: Bayat, M Davis, L Knoell, D Korth-Bradley, J Munger, M Shaefer, M Vlasses, P Wermeling, D Ujhelyi, M

Citation: M. Bayat et al., The clinical pharmacist as principal investigator, PHARMACOTHE, 20(5), 2000, pp. 599-608

Authors: Boni, J Korth-Bradley, J McGoldrick, K Appel, A Cooper, S

Citation: J. Boni et al., Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery, J CLIN PHAR, 39(7), 1999, pp. 729-737